Advertisement
Table 1 Patient characteristics
| Variables | HBeAg (-) (n=39) | HBeAg (+) (n=55) | P value | ||
|---|---|---|---|---|---|
| no. | % | no. | % | ||
| Age, <40/40-59/60≤ | 7/22/10 | 18/56/26 | 22/23/10 | 40/42/18 | 0.07 |
| Age (y/o) | 50.0 ± 11.8 | 44.3 ± 14.5 | 0.03 | ||
| Gender, female/male | 11/28 | 28/72 | 18/37 | 33/67 | 0.7 |
| Drug, LAM/ETV | 25/14 | 64/36 | 38/17 | 69/31 | 0.7 |
| ALT (IU/L), <100/100-199/200≤ | 12/16/11 | 31/41/28 | 20/13/22 | 36/24/40 | 0.19 |
| HBV-DNA (Log copy/mL), <6/6-7.6/7.6< | 11/22/6 | 28/56/15 | 4/20/31 | 7/36/56 | 0.001 |
| Genotype*, B/C | 5/26 | 16/84 | 1/37 | 3/97 | 0.07 |
| HBsAg (IU/mL)*, <1000/1000-10000/10000≤ | 7/11/5 | 30/48/22 | 3/9/8 | 15/45/40 | 0.09 |
| Histology (METAVIR Staging)*, 1/2/3 | 13/8/6 | 48/30/22 | 11/13/7 | 35/42/23 | 0.6 |
| Histology (METAVIR Grading)*, 1/2/3 | 7/17/3 | 26/63/11 | 8/15/8 | 26/48/26 | 0.3 |
